Insecticides India Limited has submitted its mandatory compliance report to BSE and NSE regarding the status of physical share transfer requests under SEBI's special re-lodgement window. The report covers the period from January 1, 2026 to January 6, 2026.

Compliance Report Details

The company filed this report on January 28, 2026, through Company Secretary Sandeep Kumar, in adherence to SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025. This circular established a special window allowing shareholders to re-lodge transfer requests for physical shares that were previously rejected or returned.

Transfer Request Status

Alankit Assignments Limited, serving as the company's Registrar and Transfer Agent, provided the following status report for the specified period:

Regulatory Framework

The SEBI circular dated July 2, 2025, mandated listed companies to report on physical share transfer activities under the special re-lodgement window. This initiative aims to facilitate shareholders who faced difficulties with physical share transfers in the past, providing them an opportunity to complete pending transactions.

Stock Exchange Communication

The report was simultaneously submitted to both major Indian stock exchanges where Insecticides India Limited shares are listed. The company trades on BSE with scrip code 532851 and on NSE under the symbol INSECTICID. Alankit Assignments Limited confirmed that this information has been shared for stock exchange records and further dissemination as required under regulatory guidelines.

Insecticides (India) Limited has announced a significant internal restructuring of its promoter shareholding through the transfer of 1,96,83,052 equity shares, representing 67.65% of the company's total shareholding. The transaction was completed on January 21, 2026, as part of a strategic family succession planning initiative.

Transaction Overview

The share transfer was executed through off-market gift transfers with NIL value, undertaken pursuant to SEBI Order No. WTM/KCV/CFD/15/2025-26 dated December 02, 2025. The company described this as a private family arrangement and non-commercial transaction designed to facilitate smooth succession planning and streamline the promoter family's assets and businesses.

Acquiring Trusts Distribution

The transferred shares have been distributed among four family trusts, with Sanskriti Family Trust receiving the largest allocation:

Transferor Details

The shares were transferred by existing promoters and their family members, with significant contributions from key management personnel:

Post-Transaction Shareholding Structure

Following the completion of the transfer, the promoter group's overall holding remains stable at 72.3% of the total equity share capital. The restructured shareholding includes both individual promoters and the newly constituted family trusts, which will be classified as part of the promoter and promoter group upon completion of the acquisition.

Regulatory Compliance

The transaction involved comprehensive regulatory filings under multiple SEBI regulations, including the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 and SEBI (Prohibition of Insider Trading) Regulations 2015. All relevant intimations were submitted to both BSE Limited and National Stock Exchange of India Limited on January 23, 2026.

Company Profile

Insecticides (India) Limited, with its registered and corporate office at Lusa Tower, Azadpur Commercial Complex, Delhi, operates with a total equity share capital of 2,90,97,837 shares. The company maintains its listing on both BSE Limited and National Stock Exchange of India Limited, ensuring continued market accessibility for investors.